Paolo A. Ascierto: Communicating hope in metastatic melanoma care
Paolo A. Ascierto, Director Department of Melanoma, Cancer Immunotherapy, Development Therapeutics at the National Cancer Institute IRCCS G. Pascale Foundation, made the following post on LinkedIn:
“Being a doctor also means communicating. In metastatic melanoma, 50% survival is a clinical triumph, achieved thanks to immunotherapy research. But for patients, the same percentage can be a frightening figure, an ‘in or out’.
The real challenge is to find the right words to help patients understand. Knowing how best to interpret the role of doctor in a way that is not just scientific. In short, communicating effectively to make living with the disease as less traumatic as possible.
Thank you Gigi Ross for the video: a masterful portrayal of patients’ reactions.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023